Key points are not available for this paper at this time.
BACKGROUND: Machine learning (ML) offers opportunities to overcome limitations of conventional survival analyses, which are commonly found in cancer studies. However, the choice and levels of performance of ML methods vary across studies. As a result, it is unclear whether they consistently outperform traditional statistical methods and whether one particular ML strategy may outperform others for survival analysis. The present study aimed to systematically review the literature around this emerging topic. METHODS: This systematic review was conducted using the PRISMA guidelines. Electronic databases were systematically searched using keywords related to Machine Learning, Survival Analysis and Cancer. RESULTS however, it was reported in only a minority of papers. This study also highlighted great variability in both methodologies and their implementations.
O’Donnell et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: